Abbott

Company Snapshot

Founded: 1888
Entity Type: Public
Employees: 115,000
Region: North America
Revenue: $44,328.0 Millions
Revenue Year: 2025
Segment: Established Pharmaceutical Products and Medical Devices
Headquarter: Illinois, U.S.
Key Geographics: U.S., Germany, China, Japan, India, Switzerland, Canada
Corporate Address: 100 Abbott Park Road, Abbott Park, Illinois 60064, U.S. Tel: +1-224-667-6100 Website: www.abbott.com

Company Overview

Abbott, a U.S.-based pharmaceutical and medical device manufacturing company, specializes in developing, manufacturing, and marketing a wide range of healthcare products. It offers a comprehensive range of diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. It operates through four segments: established pharmaceutical products, diagnostic products, nutritional products, and medical devices.

The medical devices segment includes the following subsegments: rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care. Its cardiovascular-focused subsegments collectively serve the cardiovascular devices market through a broad, integrated portfolio covering coronary, structural heart, electrophysiology, heart failure, and vascular care. This portfolio combines device innovation with data-enabled platforms to support the management of cardiovascular disease across both acute and chronic care settings.

Abbott operates in 160 countries and has a robust global network of distributors and wholesalers. It owns 89 manufacturing facilities worldwide. Its research and development centers are in the U.S., with additional locations in Colombia, India, Singapore, Spain, and the U.K.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Abbott In Reports

Cardiovascular Devices: Global Markets to 2030

BCC Research detailed report on cardiovascular devices market data using 2024 as the base year 2025 as the estimated year, and provides CAGR projections for the 2025–2030 forecast period.

Clinical Nutrition: Global Markets to 2031

Get insights into the clinical nutrition market, including enteral nutrition, parenteral nutrition, infant nutrition, regulatory trends and growth opportunities through 2030.

Pacemakers: Global Markets

BCC Research detailed report on pacemaker market revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period from 2025 through 2030.

Company's Business Segments

  • Established Pharmaceutical Products : Gastroenterology, Women’s health, Cardiovascular and metabolic, Pain and central nervous system, and Respiratory drugs and vaccines
  • Nutritional Products : Infant formula and follow-on formula, Adult and other pediatric nutritional, and Nutritional used in enteral feeding in health care institutions
  • Diagnostic Products : Core laboratory and transfusion medicine systems in the areas of immunoassay, Molecular diagnostics polymerase chain reaction (PCR) instrument systems, Point of care systems, Rapid diagnostics lateral flow testing products in the area of infectious diseases such as SARS-CoV-2, and informatics and automation solutions for use in laboratories
  • Medical Devices : Rhythm management, Electrophysiology, Heart failure, Vascular, Structural heart, Continuous glucose and blood glucose monitoring systems, and Neuromodulation

Applications/End User Industries

  • Healthcare Professionals
  • Physicians
  • Pharmacies
  • Pharmacists
  • Laboratory Technicians
  • Public Health Organizations
  • Hospitals
  • Clinics
  • Government Agencies
  • Supermarkets
  • Online Retailers
  • Pharmaceuticals
  • Healthcare
AI Sentiment